Med. praxi. 2013;10(2):72-76

Omega-3 fatty acids; from theory to clinical practice

doc.MUDr.Zdeněk Wilhelm, CSc.
Fyziologický ústav LF MU, Brno

Fats are often spoken of in negative terms whether it is in association with cholesterol or overweight or cardiovascular diseases. Such a simplified

view of lipids, however, does not reflect the reality. An example of this can be monoenoic and polyenoic fatty acids that have a wide

spectrum of very important physiological effects in the human organism and their intake is important for maintaining the health of the body.

This paper is focused on one of the groups of fatty acids, the so-called omega-3 fatty acids, that are significant for the clinical practice

not only in terms of disease prevention, but also as effective treatment of serious clinical conditions.

Keywords: MUFA, PUFA, eikosanoids ratio ω-6, ω-3

Published: February 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Wilhelm Z. Omega-3 fatty acids; from theory to clinical practice. Med. praxi. 2013;10(2):72-76.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Murray RK, et al. Harperova biochemie. Nakladatelství a vydavatelství H ? H, 2002: 872.
    2. Kolman J, Röhm K-H. Taschenatlas der Biochemie. Thieme Verlag, Stuttgart 1994: 427.
    3. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biocheistry to clinical implications in cardiovascular prevetion. Biochemical Pharmacology 2009; 77: 937-946. Go to original source... Go to PubMed...
    4. Freeman LM. Beneficia effects of omega-3 fatty acids in cardiovascular disease. Journal of Small Animal Practice. 2010; 51: 462-470. Go to original source... Go to PubMed...
    5. Goggus U, Smith Ch., ,?-3 Omega fatty acids" a review of current knowledge. International Journal of Food Science & Technology 2010; 45: 417-436. Go to original source...
    6. Lawrence GD. The fats of life. Rutgers University Press, New Brunswick 2010: 277. Go to original source...
    7. Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Progress in Lipid Research 2011; 50: 372-387. Go to original source... Go to PubMed...
    8. Eckert GP, Lipka U, Miller W. Omega-3 fatty acids in neurodegenerative disease: Focus on mitochondria. Prostaglandins, Leukotriens and Essentials Fatty Acids. 2013; 88: 105-114. Go to original source... Go to PubMed...
    9. Simopoulos AP. Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications. In: Simeopoulos AP, Meester F De: A balanced omega-6/omega-3 fatty acid ratio, cholesterol and coronary heart disease. Karger, Basel 2009: 1-21. Go to original source...
    10. Lim K, Wu T. ?-3 PUFAs and other cancers. In: Calvielo G, Serini S. Dietary omega-3 polyunsaturated fatty acids and cancor. Springer, Heidelberg, 2010: 191-217. Go to original source...
    11. Mesko D, et al. Differential diagnosis by laboratory medicine. Springer, Heidelberg 2002: 1098.
    12. Bozzetti F, Meyenfeldt MF. Nutritional support in cancer. In: Sobotka L.: Basic in clinical nutrition. Galén, Praha 2004: 392-402.
    13. Wieland E. Arteriosklerose - Hyperlipoprotenämie. In: Schadauer P, Ollenchläger G. Ernährungsmedizin. Urban ? Fischer, München 2006: 968-985. Go to original source...
    14. Eskort-Stump S. Nutrition and Diagnosis - related care. Wolters Kluwer/Lippincot Wiliams ? Wilkins, Philadelphia 2008: 948.
    15. Horn F, et al. Biochemie des Menschen. Georg Thieme Verlag, Stuttgart 2003: 596.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.